Provided by Tiger Fintech (Singapore) Pte. Ltd.

Olema Pharmaceuticals, Inc.

4.45
+0.04000.91%
Volume:625.31K
Turnover:2.76M
Market Cap:330.20M
PE:-1.95
High:4.67
Open:4.49
Low:4.31
Close:4.41
Loading ...

Olema Pharmaceuticals Inc expected to post a loss of 64 cents a share - Earnings Preview

Reuters
·
Yesterday

Olema Pharmaceuticals Price Target Maintained With a $30.00/Share by HC Wainwright & Co.

Dow Jones
·
12 Mar

Promising Efficacy of Olema Pharmaceuticals’ Palazestrant Supports Buy Rating

TIPRANKS
·
11 Mar

Olema Pharmaceuticals: Promising Clinical Results and Strong Financial Health Support Buy Rating

TIPRANKS
·
07 Mar

Olema Pharmaceuticals (OLMA) Receives a Buy from Oppenheimer

TIPRANKS
·
06 Mar

Olema Pharmaceuticals Price Target Maintained With a $30.00/Share by HC Wainwright & Co.

Dow Jones
·
06 Mar

Olema updated palazestrant combination trial, says Oppenheimer

TIPRANKS
·
06 Mar

Promising Efficacy of Olema Pharmaceuticals’ Breast Cancer Treatment Drives Buy Rating

TIPRANKS
·
05 Mar

Olema Pharmaceuticals Unveils Strategic Priorities and Pipeline

TIPRANKS
·
05 Mar

Promising Developments in Olema Pharmaceuticals’ Breast Cancer Treatment Drive Buy Rating

TIPRANKS
·
27 Feb

Olema Oncology appoints Shawnte Mitchell as Chief Legal Officer

TIPRANKS
·
18 Feb

Olema Oncology Appoints Shawnte M. Mitchell, J.d. as Chief Legal Officer and Corporate Secretary

THOMSON REUTERS
·
18 Feb

Olema Oncology Appoints Shawnte M. Mitchell, J.D. as Chief Legal Officer and Corporate Secretary

GlobeNewswire
·
18 Feb

Olema Oncology Reports Inducement Grants Under Nasdaq Listing Rule 5635(C)(4)

THOMSON REUTERS
·
05 Feb

Olema Oncology Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

GlobeNewswire
·
05 Feb

Olema Oncology to Participate in Upcoming Investor Conferences

GlobeNewswire
·
04 Feb